Common Contracts

Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed] ASSET PURCHASE AGREEMENT

Asset Purchase Agreement • February 27th, 2020 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Asset Purchase Agreement
• Filed
  February 27th, 2020
• Company
  Sonoma Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations

This ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into by and between SONOMA PHARMACEUTICALS, inc., a Corporation under the laws of Delaware hereinafter referred to as “Seller” and MicroSafe Group DMCC, an organization under the laws of the United Arab Emirates, hereinafter referred to as “Buyer” (all Parties jointly referred to as the “Parties”) as of February 21, 2020 (the “Effective Date”).

Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed] ASSET PURCHASE AGREEMENT

Asset Purchase Agreement • May 22nd, 2019 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Asset Purchase Agreement
• Filed
  May 22nd, 2019
• Company
  Sonoma Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations

This ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into by and between SONOMA PHARMACEUTICALS, inc., (previously known as Oculus Innovative sciEnces, INC.) a Corporation under the laws of Delaware hereinafter referred to as “Seller” and PETAGON LIMITED, an organization under the laws of Hong Kong, hereinafter referred to as “Buyer” (all Parties jointly referred to as the “Parties”) as of 14 May, 2019 (the “Effective Date”).